{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:17:11Z","timestamp":1791217031423,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2000,11,1]]},"DOI":"10.1038\/sj.gt.3301324","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:54:09Z","timestamp":1031158449000},"page":"1930-1939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis"],"prefix":"10.1038","volume":"7","author":[{"given":"V","family":"Cottard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bouille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mezzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Boissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,11,27]]},"reference":[{"key":"BF3301324_CR1","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","volume":"322","author":"Jr Harris ED","year":"1990","unstructured":"Harris ED Jr . Rheumatoid arthritis. Pathophysiology and implications for therapy New Engl J Med 1990 322: 1277\u20131289","journal-title":"New Engl J Med"},{"key":"BF3301324_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/rheumatology\/38.suppl_1.11","volume":"38","author":"FC Breedveld","year":"1999","unstructured":"Breedveld FC . Future trends in the treatment of rheumatoid arthritis: cytokine targets Rheumatology 1999 38: 11\u201313","journal-title":"Rheumatology"},{"key":"BF3301324_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/art.1780380202","volume":"38","author":"WP Arend","year":"1995","unstructured":"Arend WP, Dayer JM . Inhibition of the production and effects of interleukin-1 and tumor necrosis factor \u03b1 in rheumatoid arthritis Arthritis Rheum 1995 38: 151\u2013160","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR4","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","volume":"354","author":"R Maini","year":"1999","unstructured":"Maini R et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 1999 354: 1932\u20131939","journal-title":"Lancet"},{"key":"BF3301324_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate New Engl J Med 1999 340: 253\u2013259","journal-title":"New Engl J Med"},{"key":"BF3301324_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/art.1780390513","volume":"39","author":"LA Joosten","year":"1996","unstructured":"Joosten LA, Helsen MM, van de Loo FA, van den Berg WB . Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha\/beta, and IL-1Ra Arthritis Rheum 1996 39: 797\u2013809","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR7","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1073\/pnas.95.8.4613","volume":"95","author":"SC Ghivizzani","year":"1998","unstructured":"Ghivizzani SC et al. Direct adenovirus-mediated gene transfer of interleukin-1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects Proc Natl Acad Sci USA 1998 95: 4613\u20134618","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301324_CR8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/art.1780400517","volume":"40","author":"AC Bakker","year":"1997","unstructured":"Bakker AC et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee Arthritis Rheum 1997 40: 893\u2013900","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR9","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.4049\/jimmunol.156.9.3558","volume":"156","author":"K Otani","year":"1996","unstructured":"Otani K et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy J Immunol 1996 156: 3558\u20133562","journal-title":"J Immunol"},{"key":"BF3301324_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/1529-0131(200002)43:2<289::AID-ANR8>3.0.CO;2-H","volume":"43","author":"RY Pan","year":"2000","unstructured":"Pan RY et al. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist Arthritis Rheum 2000 43: 289\u2013297","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/1521-4141(200003)30:3<867::AID-IMMU867>3.0.CO;2-M","volume":"30","author":"N Bessis","year":"2000","unstructured":"Bessis N et al. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis Eur J Immunol 2000 30: 867\u2013875","journal-title":"Eur J Immunol"},{"key":"BF3301324_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1084\/jem.146.3.857","volume":"146","author":"DE Trentham","year":"1977","unstructured":"Trentham DE, Townes AS, Kang AH . Autoimmunity to type II collagen an experimental model of arthritis J Exp Med 1977 146: 857\u2013868","journal-title":"J Exp Med"},{"key":"BF3301324_CR13","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/283666a0","volume":"283","author":"JS Courtenay","year":"1980","unstructured":"Courtenay JS et al. Immunisation against heterologous type II collagen induces arthrtis in mice Nature 1980 283: 666\u2013668","journal-title":"Nature"},{"key":"BF3301324_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI7317","volume":"104","author":"JA Gracie","year":"1999","unstructured":"Gracie JA et al. A proinflammatory role for IL-18 in rheumatoid arthritis J Clin Invest 1999 104: 1393\u20131401","journal-title":"J Clin Invest"},{"key":"BF3301324_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium Arthritis Rheum 1999 42: 963\u2013970","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR16","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/eji.1830261020","volume":"26","author":"N Bessis","year":"1996","unstructured":"Bessis N et al. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 Eur J Immunol 1996 26: 2399\u20132403","journal-title":"Eur J Immunol"},{"key":"BF3301324_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2249.1998.00500.x","volume":"111","author":"N Bessis","year":"1998","unstructured":"Bessis N et al. Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13 Clin Exp Immunol 1998 111: 391\u2013396","journal-title":"Clin Exp Immunol"},{"key":"BF3301324_CR18","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/art.1780380805","volume":"38","author":"P Chomarat","year":"1995","unstructured":"Chomarat P, Banchereau J, Miossec P . Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis Arthritis Rheum 1995 38: 1046\u20131054","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/eji.1830260716","volume":"26","author":"C Mauri","year":"1996","unstructured":"Mauri C, Williams RO, Walmsley M, Feldmann M . Relationship between Th1\/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis Eur J Immunol 1996 26: 1511\u20131518","journal-title":"Eur J Immunol"},{"key":"BF3301324_CR20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/eji.1830270623","volume":"27","author":"A Doncarli","year":"1997","unstructured":"Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O . Conversion in vivo from an early dominant Th0\/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis Eur J Immunol 1997 27: 1451\u20131458","journal-title":"Eur J Immunol"},{"key":"BF3301324_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2249.1999.00959.x","volume":"117","author":"N Bessis","year":"1999","unstructured":"Bessis N et al. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA) Clin Exp Immunol 1999 117: 376\u2013382","journal-title":"Clin Exp Immunol"},{"key":"BF3301324_CR22","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.4049\/jimmunol.159.11.5687","volume":"159","author":"AC Horsfall","year":"1997","unstructured":"Horsfall AC et al. Suppression of collagen-induced arthritis by continuous administration of IL-4 J Immunol 1997 159: 5687\u20135696","journal-title":"J Immunol"},{"key":"BF3301324_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/art.1780390318","volume":"39","author":"M Walmsley","year":"1996","unstructured":"Walmsley M et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis Arthritis Rheum 1996 39: 495\u2013503","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR24","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.151.8.4344","volume":"151","author":"JB Allen","year":"1993","unstructured":"Allen JB et al. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis J Immunol 1993 151: 4344\u20134351","journal-title":"J Immunol"},{"key":"BF3301324_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4","volume":"42","author":"CH Evans","year":"1999","unstructured":"Evans CH et al. Gene therapy for rheumatic diseases Arthritis Rheum 1999 42: 1\u201316","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1073\/pnas.93.1.402","volume":"93","author":"SS Makarov","year":"1996","unstructured":"Makarov SS et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA Proc Natl Acad Sci USA 1996 93: 402\u2013406","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301324_CR27","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.160.11.5213","volume":"160","author":"F Apparailly","year":"1998","unstructured":"Apparailly F et al. Adenovirus mediated transfer of viral IL-10 gene inhibits collagen-induced arthritis J Immunol 1998 160: 5213\u20135220","journal-title":"J Immunol"},{"key":"BF3301324_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/BC.1999.078","volume":"380","author":"H Bueler","year":"1999","unstructured":"Bueler H . Adeno-associated viral vectors for gene transfer and gene therapy Biol Chem 1999 380: 613\u2013622","journal-title":"Biol Chem"},{"key":"BF3301324_CR29","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule N et al. Immune responses to adenovirus and adeno-associated virus in humans Gene Therapy 1999 6: 1574\u20131583","journal-title":"Gene Therapy"},{"key":"BF3301324_CR30","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.4049\/jimmunol.163.8.4546","volume":"163","author":"E Lubberts","year":"1999","unstructured":"Lubberts E et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction J Immunol 1999 163: 4546\u20134556","journal-title":"J Immunol"},{"key":"BF3301324_CR31","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/sj.gt.3301049","volume":"6","author":"DL Boyle","year":"1999","unstructured":"Boyle DL et al. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2 activity Gene Therapy 1999 6: 1911\u20131918","journal-title":"Gene Therapy"},{"key":"BF3301324_CR32","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.4049\/jimmunol.162.6.3625","volume":"162","author":"JD Whalen","year":"1999","unstructured":"Whalen JD et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws J Immunol 1999 162: 3625\u20133632","journal-title":"J Immunol"},{"key":"BF3301324_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.4049\/jimmunol.164.3.1576","volume":"164","author":"KN Kim","year":"2000","unstructured":"Kim KN et al. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer J Immunol 2000 164: 1576\u20131581","journal-title":"J Immunol"},{"key":"BF3301324_CR34","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4049\/jimmunol.163.4.2202","volume":"163","author":"ER Lechman","year":"1999","unstructured":"Lechman ER et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees J Immunol 1999 163: 2202\u20132208","journal-title":"J Immunol"},{"key":"BF3301324_CR35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.4049\/jimmunol.154.3.1432","volume":"154","author":"P Chomarat","year":"1995","unstructured":"Chomarat P et al. Balance of IL-1 receptor antagonist\/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10 J Immunol 1995 154: 1432\u20131439","journal-title":"J Immunol"},{"key":"BF3301324_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1006\/cyto.1995.1024","volume":"7","author":"J Dechanet","year":"1995","unstructured":"Dechanet J, Rissoan MC, Banchereau J, Miossec P . Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes Cytokine 1995 7: 176\u2013183","journal-title":"Cytokine"},{"key":"BF3301324_CR37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B","volume":"41","author":"RC Borghaei","year":"1998","unstructured":"Borghaei RC, Rawlings PL Jr, Mochan E . Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts Arthritis Rheum 1998 41: 1398\u20131406","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1126\/science.8332913","volume":"261","author":"F Colotta","year":"1993","unstructured":"Colotta F et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4 Science 1993 261: 472\u2013475","journal-title":"Science"},{"key":"BF3301324_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/1043-4666(93)90006-Q","volume":"5","author":"AP Cope","year":"1993","unstructured":"Cope AP et al. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells Cytokine 1993 5: 205\u2013212","journal-title":"Cytokine"},{"key":"BF3301324_CR40","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.184.3.1093","volume":"184","author":"R Mueller","year":"1996","unstructured":"Mueller R, Krahl T, Sarvetnick N . Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice J Exp Med 1996 184: 1093\u20131099","journal-title":"J Exp Med"},{"key":"BF3301324_CR41","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1084\/jem.185.9.1711","volume":"185","author":"MK Shaw","year":"1997","unstructured":"Shaw MK et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis J Exp Med 1997 185: 1711\u20131714","journal-title":"J Exp Med"},{"key":"BF3301324_CR42","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1089\/hum.1997.8.16-1891","volume":"8","author":"RO Snyder","year":"1997","unstructured":"Snyder RO et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice Hum Gene Ther 1997 8: 1891\u20131900","journal-title":"Hum Gene Ther"},{"key":"BF3301324_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm0397-306","volume":"3","author":"KJ Fisher","year":"1997","unstructured":"Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nature Med 1997 3: 306\u2013312","journal-title":"Nature Med"},{"key":"BF3301324_CR44","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/2625","volume":"4","author":"MJ During","year":"1998","unstructured":"During MJ et al. Peroral gene therapy of lactose intolerance using an adeno-associated virus vector Nature Med 1998 4: 1131\u20131135","journal-title":"Nature Med"},{"key":"BF3301324_CR45","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/sj.gt.3300782","volume":"5","author":"RP Haberman","year":"1998","unstructured":"Haberman RP, McCown TJ, Samulski RJ . Inducible long-term gene expression in brain with adeno-associated virus gene transfer Gene Therapy 1998 5: 1604\u20131611","journal-title":"Gene Therapy"},{"key":"BF3301324_CR46","doi-asserted-by":"publisher","first-page":"14083","DOI":"10.1073\/pnas.94.25.14083","volume":"94","author":"RJ Mandel","year":"1997","unstructured":"Mandel RJ, Spratt SK, Snyder RO, Leff SE . Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats Proc Natl Acad Sci USA 1997 94: 14083\u201314088","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3301324_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/4743","volume":"5","author":"RW Herzog","year":"1999","unstructured":"Herzog RW et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector Nature Med 1999 5: 56\u201363","journal-title":"Nature Med"},{"key":"BF3301324_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.gt.3300648","volume":"5","author":"S Zhou","year":"1998","unstructured":"Zhou S, Murphy JE, Escobedo JA, Dwarki VJ . Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates Gene Therapy 1998 5: 665\u2013670","journal-title":"Gene Therapy"},{"key":"BF3301324_CR49","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.163.2.1000","volume":"163","author":"E Quattrocchi","year":"1999","unstructured":"Quattrocchi E et al. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis J Immunol 1999 163: 1000\u20131009","journal-title":"J Immunol"},{"key":"BF3301324_CR50","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/10430349950018139","volume":"10","author":"PH Goossens","year":"1999","unstructured":"Goossens PH et al. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys Hum Gene Ther 1999 10: 1139\u20131149","journal-title":"Hum Gene Ther"},{"key":"BF3301324_CR51","first-page":"2076","volume":"24","author":"C Jorgensen","year":"1997","unstructured":"Jorgensen C et al. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice J Rheumatol 1997 24: 2076\u20132079","journal-title":"J Rheumatol"},{"key":"BF3301324_CR52","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1172\/JCI119726","volume":"100","author":"H Zhang","year":"1997","unstructured":"Zhang H et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1\/Fas)-ligand gene transfer J Clin Invest 1997 100: 1951\u20131957","journal-title":"J Clin Invest"},{"key":"BF3301324_CR53","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1128\/JVI.72.5.4212-4223.1998","volume":"72","author":"K Jooss","year":"1998","unstructured":"Jooss K, Yang Y, Fisher KJ, Wilson JM . Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers J Virol 1998 72: 4212\u20134223","journal-title":"J Virol"},{"key":"BF3301324_CR54","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/jvi.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098\u20138108","journal-title":"J Virol"},{"key":"BF3301324_CR55","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1128\/jvi.71.8.5932-5941.1997","volume":"71","author":"CL Halbert","year":"1997","unstructured":"Halbert CL et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration J Virol 1997 71: 5932\u20135941","journal-title":"J Virol"},{"key":"BF3301324_CR56","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1006\/clim.1999.4724","volume":"92","author":"DG Brockstedt","year":"1999","unstructured":"Brockstedt DG et al. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration Clin Immunol 1999 92: 67\u201375","journal-title":"Clin Immunol"},{"key":"BF3301324_CR57","first-page":"983","volume":"27","author":"J Goater","year":"2000","unstructured":"Goater J et al. Empirical advantages of adeno-associated viral vectors for in vivo gene therapy for arthritis J Rheumatol 2000 27: 983\u2013989","journal-title":"J Rheumatol"},{"key":"BF3301324_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.283.5398.88","volume":"283","author":"X Ye","year":"1999","unstructured":"Ye X et al. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer Science 1999 283: 88\u201391","journal-title":"Science"},{"key":"BF3301324_CR59","volume-title":"Production of Recombinant Adeno-associated Viral Vectors","author":"O Snyder","year":"1996","unstructured":"Snyder O, Xiao XP, Samulski RJ . Current protocols in human genetics. In: Dracopoli NC et al (eds) Production of Recombinant Adeno-associated Viral Vectors J Wiley: USA 1996 unit 12.1"},{"key":"BF3301324_CR60","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","volume":"72","author":"X Xiao","year":"1998","unstructured":"Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helperadenovirus J Virol 1998 72: 2224\u20132232","journal-title":"J Virol"},{"key":"BF3301324_CR61","first-page":"211","volume":"6","author":"G Braas","year":"1996","unstructured":"Braas G, Searle PF, Slater NK, Lyddiatt A . Strategies for the isolation and purification of retroviral vectors for gene therapy Bioseparation 1996 6: 211\u2013228","journal-title":"Bioseparation"},{"key":"BF3301324_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0958-1669(98)80112-2","volume":"9","author":"A Lyddiatt","year":"1998","unstructured":"Lyddiatt A, O'Sullivan DA . Biochemical recovery and purification of gene therapy vectors Curr Opin Biotechnol 1998 9: 177\u2013185","journal-title":"Curr Opin Biotechnol"},{"key":"BF3301324_CR63","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/hum.1998.9.5-695","volume":"9","author":"A Salvetti","year":"1998","unstructured":"Salvetti A et al. Factors influencing recombinant adeno-associated virus production Hum Gene Ther 1998 9: 695\u2013706","journal-title":"Hum Gene Ther"},{"key":"BF3301324_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.1780330101","volume":"33","author":"M-C Boissier","year":"1990","unstructured":"Boissier M-C et al. Arthritogenicity of minor cartilage collagens (type IX and XI) in mice Arthritis Rheum 1990 33: 1\u20138","journal-title":"Arthritis Rheum"},{"key":"BF3301324_CR65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/ard.46.9.691","volume":"46","author":"M-C Boissier","year":"1987","unstructured":"Boissier M-C et al. Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis Ann Rheum Dis 1987 46: 691\u2013700","journal-title":"Ann Rheum Dis"},{"key":"BF3301324_CR66","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.4049\/jimmunol.158.11.5501","volume":"158","author":"B Manoury-Schwartz","year":"1997","unstructured":"Manoury-Schwartz B et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors J Immunol 1997 158: 5501\u20135506","journal-title":"J Immunol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301324","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:15:33Z","timestamp":1682036133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":66,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2000,11,1]]}},"alternative-id":["BF3301324"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301324","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,1]]},"assertion":[{"value":"22 June 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}